HEADER TRANSFERASE 16-MAR-21 7NWA TITLE CRYSTAL STRUCTURE OF HUMAN CYTOSOLIC BRANCHED-CHAIN AMINOTRANSFERASE TITLE 2 (BCAT1) IN COMPLEX WITH PLP AND COMPOUND A COMPND MOL_ID: 1; COMPND 2 MOLECULE: BRANCHED-CHAIN-AMINO-ACID AMINOTRANSFERASE, CYTOSOLIC; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: BCAT(C),PROTEIN ECA39, BCAT 1; COMPND 5 EC: 2.6.1.42; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 OTHER_DETAILS: SYNONYM: BCAT(C), BCAT1 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BCAT1, BCT1, ECA39; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS BRANCHED-CHAIN-AMINO-ACID AMINOTRANSFERASE, PYRIDOXAL-PHOSPHATE- KEYWDS 2 DEPENDENT AMINOTRANSFERASE, TRANSFERASE, SMALL MOLECULE INHIBITOR EXPDTA X-RAY DIFFRACTION AUTHOR R.C.HILLIG REVDAT 3 31-JAN-24 7NWA 1 REMARK REVDAT 2 23-NOV-22 7NWA 1 JRNL REVDAT 1 02-NOV-22 7NWA 0 JRNL AUTH J.GUNTHER,R.C.HILLIG,K.ZIMMERMANN,S.KAULFUSS,C.LEMOS, JRNL AUTH 2 D.NGUYEN,H.REHWINKEL,M.HABGOOD,C.LECHNER,R.NEUHAUS,U.GANZER, JRNL AUTH 3 M.DREWES,J.CHAI,L.BOUCHE JRNL TITL BAY-069, A NOVEL (TRIFLUOROMETHYL)PYRIMIDINEDIONE-BASED JRNL TITL 2 BCAT1/2 INHIBITOR AND CHEMICAL PROBE. JRNL REF J.MED.CHEM. V. 65 14366 2022 JRNL REFN ISSN 0022-2623 JRNL PMID 36261130 JRNL DOI 10.1021/ACS.JMEDCHEM.2C00441 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH S.M.BERTRAND REMARK 1 TITL THE DISCOVERY OF IN VIVO ACTIVE MITOCHONDRIAL BRANCHED-CHAIN REMARK 1 TITL 2 AMINOTRANSFERASE (BCATM) INHIBITORS BY HYBRIDIZING FRAGMENT REMARK 1 TITL 3 AND HTS HITS REMARK 1 REF J MED CHEM V. 58 7140 2015 REMARK 1 REFN ISSN 0022-2623 REMARK 1 PMID 26090771 REMARK 2 REMARK 2 RESOLUTION. 1.59 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0267 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.59 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.49 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 3 NUMBER OF REFLECTIONS : 98439 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.170 REMARK 3 R VALUE (WORKING SET) : 0.168 REMARK 3 FREE R VALUE : 0.199 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 5181 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.59 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.63 REMARK 3 REFLECTION IN BIN (WORKING SET) : 6369 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 86.84 REMARK 3 BIN R VALUE (WORKING SET) : 0.2770 REMARK 3 BIN FREE R VALUE SET COUNT : 335 REMARK 3 BIN FREE R VALUE : 0.2800 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5775 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 83 REMARK 3 SOLVENT ATOMS : 706 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 28.28 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.66 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.39000 REMARK 3 B22 (A**2) : 1.15000 REMARK 3 B33 (A**2) : 1.24000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.083 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.084 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.063 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.543 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.969 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.959 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 6129 ; 0.009 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 5708 ; 0.002 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 8369 ; 1.543 ; 1.656 REMARK 3 BOND ANGLES OTHERS (DEGREES): 13166 ; 1.407 ; 1.578 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 757 ; 6.787 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 294 ;36.852 ;22.925 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1015 ;13.964 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 30 ;15.893 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 776 ; 0.078 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6935 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1365 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 22 A 386 REMARK 3 ORIGIN FOR THE GROUP (A): -36.0870 6.7040 17.4640 REMARK 3 T TENSOR REMARK 3 T11: 0.1494 T22: 0.0528 REMARK 3 T33: 0.0738 T12: 0.0257 REMARK 3 T13: -0.0049 T23: -0.0498 REMARK 3 L TENSOR REMARK 3 L11: 0.7944 L22: 0.4160 REMARK 3 L33: 0.7468 L12: 0.1248 REMARK 3 L13: -0.2420 L23: -0.0020 REMARK 3 S TENSOR REMARK 3 S11: 0.0437 S12: -0.0619 S13: 0.1751 REMARK 3 S21: -0.0342 S22: -0.0713 S23: 0.0829 REMARK 3 S31: -0.1481 S32: -0.1332 S33: 0.0276 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 22 B 386 REMARK 3 ORIGIN FOR THE GROUP (A): -11.0710 -12.1250 4.4340 REMARK 3 T TENSOR REMARK 3 T11: 0.1194 T22: 0.0206 REMARK 3 T33: 0.0190 T12: -0.0098 REMARK 3 T13: 0.0138 T23: -0.0005 REMARK 3 L TENSOR REMARK 3 L11: 0.5628 L22: 0.4950 REMARK 3 L33: 0.5915 L12: -0.2512 REMARK 3 L13: 0.2183 L23: -0.1836 REMARK 3 S TENSOR REMARK 3 S11: 0.0024 S12: 0.0157 S13: 0.0573 REMARK 3 S21: 0.0074 S22: -0.0250 S23: -0.0890 REMARK 3 S31: 0.0044 S32: 0.0833 S33: 0.0226 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. U VALUES: WITH TLS ADDED. REMARK 4 REMARK 4 7NWA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 17-MAR-21. REMARK 100 THE DEPOSITION ID IS D_1292114704. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-NOV-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9184 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS JANUARY 10, 2014 REMARK 200 DATA SCALING SOFTWARE : POINTLESS 1.9.16 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 103620 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.590 REMARK 200 RESOLUTION RANGE LOW (A) : 48.490 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 200 DATA REDUNDANCY : 4.260 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.59 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.68 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.3 REMARK 200 DATA REDUNDANCY IN SHELL : 3.20 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.140 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2ABJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.12 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.24 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN AT 17 MG/ML IN 10 MILLIMOLAR REMARK 280 TRIS-HCL PH 8.0, 100 MILLIMOLAR NACL, 3 MILLIMOLAR DTT. PROTEIN REMARK 280 PREINCUBATED OVER NIGHT AT 293 K WITH 10 MILLIMOLAR 3-PHENYL- REMARK 280 PROPIONATE, 3 MILLIMOLAR DTT AND 1.5 MILLIMOLAR PLP. DROPS MADE REMARK 280 FROM 1 MICROLITER PROTEIN AND 1 MICROLITER RESERVOIR (225 REMARK 280 MILLIMOLAR MGCL2, 16-20 % (W/V) PEG 3350). INHIBITOR SOAKED INTO REMARK 280 PREFORMED CRYSTALS FOR 5 DAYS AT 10 MILLIMOLAR. CRYO: RESERVOIR REMARK 280 SOLUTION COMPLEMENTED WITH 20 % (V/V) GLYCEROL AND 10 MILLIMOLAR REMARK 280 INHIBITOR, VAPOR DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 33.49300 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 54.49100 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 53.15800 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 54.49100 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.49300 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 53.15800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5910 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 26720 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -35.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -2 REMARK 465 PRO A -1 REMARK 465 GLY A 0 REMARK 465 MET A 1 REMARK 465 LYS A 2 REMARK 465 ASP A 3 REMARK 465 CYS A 4 REMARK 465 SER A 5 REMARK 465 ASN A 6 REMARK 465 GLY A 7 REMARK 465 CYS A 8 REMARK 465 SER A 9 REMARK 465 ALA A 10 REMARK 465 GLU A 11 REMARK 465 CYS A 12 REMARK 465 THR A 13 REMARK 465 GLY A 14 REMARK 465 GLU A 15 REMARK 465 GLY A 16 REMARK 465 GLY A 17 REMARK 465 SER A 18 REMARK 465 LYS A 19 REMARK 465 GLU A 20 REMARK 465 VAL A 21 REMARK 465 GLY B -2 REMARK 465 PRO B -1 REMARK 465 GLY B 0 REMARK 465 MET B 1 REMARK 465 LYS B 2 REMARK 465 ASP B 3 REMARK 465 CYS B 4 REMARK 465 SER B 5 REMARK 465 ASN B 6 REMARK 465 GLY B 7 REMARK 465 CYS B 8 REMARK 465 SER B 9 REMARK 465 ALA B 10 REMARK 465 GLU B 11 REMARK 465 CYS B 12 REMARK 465 THR B 13 REMARK 465 GLY B 14 REMARK 465 GLU B 15 REMARK 465 GLY B 16 REMARK 465 GLY B 17 REMARK 465 SER B 18 REMARK 465 LYS B 19 REMARK 465 GLU B 20 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 360 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OH TYR A 227 O3 PLP A 402 1.71 REMARK 500 OH TYR B 227 O3 PLP B 402 2.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 309 NE - CZ - NH1 ANGL. DEV. = 4.4 DEGREES REMARK 500 ARG A 309 NE - CZ - NH2 ANGL. DEV. = -5.1 DEGREES REMARK 500 ARG B 292 NE - CZ - NH1 ANGL. DEV. = 4.9 DEGREES REMARK 500 ARG B 292 NE - CZ - NH2 ANGL. DEV. = -3.4 DEGREES REMARK 500 ARG B 324 NE - CZ - NH1 ANGL. DEV. = 3.8 DEGREES REMARK 500 ARG B 324 NE - CZ - NH2 ANGL. DEV. = -4.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 336 -73.00 71.60 REMARK 500 GLN B 112 53.20 33.79 REMARK 500 VAL B 336 -73.44 74.87 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B 403 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP B 133 OD2 REMARK 620 2 HOH B 517 O 93.2 REMARK 620 3 HOH B 556 O 91.2 172.0 REMARK 620 4 HOH B 584 O 90.8 92.4 94.2 REMARK 620 5 HOH B 615 O 179.3 87.2 88.6 88.5 REMARK 620 6 HOH B 645 O 87.7 86.0 87.5 177.8 93.0 REMARK 620 N 1 2 3 4 5 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7NTR RELATED DB: PDB REMARK 900 SAME PROTEIN IN APO FORM DBREF 7NWA A 1 386 UNP P54687 BCAT1_HUMAN 1 386 DBREF 7NWA B 1 386 UNP P54687 BCAT1_HUMAN 1 386 SEQADV 7NWA GLY A -2 UNP P54687 EXPRESSION TAG SEQADV 7NWA PRO A -1 UNP P54687 EXPRESSION TAG SEQADV 7NWA GLY A 0 UNP P54687 EXPRESSION TAG SEQADV 7NWA ARG A 379 UNP P54687 SER 379 ENGINEERED MUTATION SEQADV 7NWA GLY B -2 UNP P54687 EXPRESSION TAG SEQADV 7NWA PRO B -1 UNP P54687 EXPRESSION TAG SEQADV 7NWA GLY B 0 UNP P54687 EXPRESSION TAG SEQADV 7NWA ARG B 379 UNP P54687 SER 379 ENGINEERED MUTATION SEQRES 1 A 389 GLY PRO GLY MET LYS ASP CYS SER ASN GLY CYS SER ALA SEQRES 2 A 389 GLU CYS THR GLY GLU GLY GLY SER LYS GLU VAL VAL GLY SEQRES 3 A 389 THR PHE LYS ALA LYS ASP LEU ILE VAL THR PRO ALA THR SEQRES 4 A 389 ILE LEU LYS GLU LYS PRO ASP PRO ASN ASN LEU VAL PHE SEQRES 5 A 389 GLY THR VAL PHE THR ASP HIS MET LEU THR VAL GLU TRP SEQRES 6 A 389 SER SER GLU PHE GLY TRP GLU LYS PRO HIS ILE LYS PRO SEQRES 7 A 389 LEU GLN ASN LEU SER LEU HIS PRO GLY SER SER ALA LEU SEQRES 8 A 389 HIS TYR ALA VAL GLU LEU PHE GLU GLY LEU LYS ALA PHE SEQRES 9 A 389 ARG GLY VAL ASP ASN LYS ILE ARG LEU PHE GLN PRO ASN SEQRES 10 A 389 LEU ASN MET ASP ARG MET TYR ARG SER ALA VAL ARG ALA SEQRES 11 A 389 THR LEU PRO VAL PHE ASP LYS GLU GLU LEU LEU GLU CYS SEQRES 12 A 389 ILE GLN GLN LEU VAL LYS LEU ASP GLN GLU TRP VAL PRO SEQRES 13 A 389 TYR SER THR SER ALA SER LEU TYR ILE ARG PRO THR PHE SEQRES 14 A 389 ILE GLY THR GLU PRO SER LEU GLY VAL LYS LYS PRO THR SEQRES 15 A 389 LYS ALA LEU LEU PHE VAL LEU LEU SER PRO VAL GLY PRO SEQRES 16 A 389 TYR PHE SER SER GLY THR PHE ASN PRO VAL SER LEU TRP SEQRES 17 A 389 ALA ASN PRO LYS TYR VAL ARG ALA TRP LYS GLY GLY THR SEQRES 18 A 389 GLY ASP CYS LYS MET GLY GLY ASN TYR GLY SER SER LEU SEQRES 19 A 389 PHE ALA GLN CYS GLU ALA VAL ASP ASN GLY CYS GLN GLN SEQRES 20 A 389 VAL LEU TRP LEU TYR GLY GLU ASP HIS GLN ILE THR GLU SEQRES 21 A 389 VAL GLY THR MET ASN LEU PHE LEU TYR TRP ILE ASN GLU SEQRES 22 A 389 ASP GLY GLU GLU GLU LEU ALA THR PRO PRO LEU ASP GLY SEQRES 23 A 389 ILE ILE LEU PRO GLY VAL THR ARG ARG CYS ILE LEU ASP SEQRES 24 A 389 LEU ALA HIS GLN TRP GLY GLU PHE LYS VAL SER GLU ARG SEQRES 25 A 389 TYR LEU THR MET ASP ASP LEU THR THR ALA LEU GLU GLY SEQRES 26 A 389 ASN ARG VAL ARG GLU MET PHE GLY SER GLY THR ALA CYS SEQRES 27 A 389 VAL VAL CYS PRO VAL SER ASP ILE LEU TYR LYS GLY GLU SEQRES 28 A 389 THR ILE HIS ILE PRO THR MET GLU ASN GLY PRO LYS LEU SEQRES 29 A 389 ALA SER ARG ILE LEU SER LYS LEU THR ASP ILE GLN TYR SEQRES 30 A 389 GLY ARG GLU GLU ARG ASP TRP THR ILE VAL LEU SER SEQRES 1 B 389 GLY PRO GLY MET LYS ASP CYS SER ASN GLY CYS SER ALA SEQRES 2 B 389 GLU CYS THR GLY GLU GLY GLY SER LYS GLU VAL VAL GLY SEQRES 3 B 389 THR PHE LYS ALA LYS ASP LEU ILE VAL THR PRO ALA THR SEQRES 4 B 389 ILE LEU LYS GLU LYS PRO ASP PRO ASN ASN LEU VAL PHE SEQRES 5 B 389 GLY THR VAL PHE THR ASP HIS MET LEU THR VAL GLU TRP SEQRES 6 B 389 SER SER GLU PHE GLY TRP GLU LYS PRO HIS ILE LYS PRO SEQRES 7 B 389 LEU GLN ASN LEU SER LEU HIS PRO GLY SER SER ALA LEU SEQRES 8 B 389 HIS TYR ALA VAL GLU LEU PHE GLU GLY LEU LYS ALA PHE SEQRES 9 B 389 ARG GLY VAL ASP ASN LYS ILE ARG LEU PHE GLN PRO ASN SEQRES 10 B 389 LEU ASN MET ASP ARG MET TYR ARG SER ALA VAL ARG ALA SEQRES 11 B 389 THR LEU PRO VAL PHE ASP LYS GLU GLU LEU LEU GLU CYS SEQRES 12 B 389 ILE GLN GLN LEU VAL LYS LEU ASP GLN GLU TRP VAL PRO SEQRES 13 B 389 TYR SER THR SER ALA SER LEU TYR ILE ARG PRO THR PHE SEQRES 14 B 389 ILE GLY THR GLU PRO SER LEU GLY VAL LYS LYS PRO THR SEQRES 15 B 389 LYS ALA LEU LEU PHE VAL LEU LEU SER PRO VAL GLY PRO SEQRES 16 B 389 TYR PHE SER SER GLY THR PHE ASN PRO VAL SER LEU TRP SEQRES 17 B 389 ALA ASN PRO LYS TYR VAL ARG ALA TRP LYS GLY GLY THR SEQRES 18 B 389 GLY ASP CYS LYS MET GLY GLY ASN TYR GLY SER SER LEU SEQRES 19 B 389 PHE ALA GLN CYS GLU ALA VAL ASP ASN GLY CYS GLN GLN SEQRES 20 B 389 VAL LEU TRP LEU TYR GLY GLU ASP HIS GLN ILE THR GLU SEQRES 21 B 389 VAL GLY THR MET ASN LEU PHE LEU TYR TRP ILE ASN GLU SEQRES 22 B 389 ASP GLY GLU GLU GLU LEU ALA THR PRO PRO LEU ASP GLY SEQRES 23 B 389 ILE ILE LEU PRO GLY VAL THR ARG ARG CYS ILE LEU ASP SEQRES 24 B 389 LEU ALA HIS GLN TRP GLY GLU PHE LYS VAL SER GLU ARG SEQRES 25 B 389 TYR LEU THR MET ASP ASP LEU THR THR ALA LEU GLU GLY SEQRES 26 B 389 ASN ARG VAL ARG GLU MET PHE GLY SER GLY THR ALA CYS SEQRES 27 B 389 VAL VAL CYS PRO VAL SER ASP ILE LEU TYR LYS GLY GLU SEQRES 28 B 389 THR ILE HIS ILE PRO THR MET GLU ASN GLY PRO LYS LEU SEQRES 29 B 389 ALA SER ARG ILE LEU SER LYS LEU THR ASP ILE GLN TYR SEQRES 30 B 389 GLY ARG GLU GLU ARG ASP TRP THR ILE VAL LEU SER HET UTT A 401 26 HET PLP A 402 15 HET UTT B 401 26 HET PLP B 402 15 HET MG B 403 1 HETNAM UTT 2-[[4-CHLORANYL-2,6-BIS(FLUORANYL)PHENYL]METHYLAMINO]- HETNAM 2 UTT 7-OXIDANYLIDENE-5-PROPYL-4H-PYRAZOLO[1,5-A]PYRIMIDINE- HETNAM 3 UTT 3-CARBONITRILE HETNAM PLP PYRIDOXAL-5'-PHOSPHATE HETNAM MG MAGNESIUM ION HETSYN UTT 2-[[4-CHLORANYL-2,6-BIS(FLUORANYL)PHENYL]METHYLAMINO]- HETSYN 2 UTT 7-OXIDANYLIDENE-5-PROPYL-4~{H}-PYRAZOLO[1,5- HETSYN 3 UTT A]PYRIMIDINE-3-CARBONITRILE HETSYN PLP VITAMIN B6 PHOSPHATE FORMUL 3 UTT 2(C17 H14 CL F2 N5 O) FORMUL 4 PLP 2(C8 H10 N O6 P) FORMUL 7 MG MG 2+ FORMUL 8 HOH *706(H2 O) HELIX 1 AA1 LYS A 26 LEU A 30 5 5 HELIX 2 AA2 SER A 85 TYR A 90 1 6 HELIX 3 AA3 GLN A 112 THR A 128 1 17 HELIX 4 AA4 ASP A 133 ASP A 148 1 16 HELIX 5 AA5 GLN A 149 VAL A 152 5 4 HELIX 6 AA6 MET A 223 GLY A 228 5 6 HELIX 7 AA7 SER A 229 ASN A 240 1 12 HELIX 8 AA8 GLY A 288 GLY A 302 1 15 HELIX 9 AA9 THR A 312 GLY A 322 1 11 HELIX 10 AB1 PRO A 353 GLY A 358 5 6 HELIX 11 AB2 PRO A 359 TYR A 374 1 16 HELIX 12 AB3 LYS B 26 LEU B 30 5 5 HELIX 13 AB4 SER B 85 TYR B 90 1 6 HELIX 14 AB5 GLN B 112 THR B 128 1 17 HELIX 15 AB6 ASP B 133 ASP B 148 1 16 HELIX 16 AB7 GLN B 149 VAL B 152 5 4 HELIX 17 AB8 GLY B 224 SER B 229 1 6 HELIX 18 AB9 SER B 230 ASN B 240 1 11 HELIX 19 AC1 GLY B 288 GLY B 302 1 15 HELIX 20 AC2 THR B 312 GLY B 322 1 11 HELIX 21 AC3 PRO B 353 GLY B 358 5 6 HELIX 22 AC4 PRO B 359 TYR B 374 1 16 SHEET 1 AA1 6 ILE A 31 VAL A 32 0 SHEET 2 AA1 6 HIS A 72 PRO A 75 1 O ILE A 73 N ILE A 31 SHEET 3 AA1 6 HIS A 56 SER A 63 -1 N THR A 59 O HIS A 72 SHEET 4 AA1 6 LYS A 180 VAL A 190 -1 O LEU A 183 N VAL A 60 SHEET 5 AA1 6 SER A 159 GLY A 168 -1 N ARG A 163 O LEU A 186 SHEET 6 AA1 6 GLU A 93 PHE A 95 -1 N LEU A 94 O PHE A 166 SHEET 1 AA2 7 GLY A 67 TRP A 68 0 SHEET 2 AA2 7 HIS A 56 SER A 63 -1 N SER A 63 O GLY A 67 SHEET 3 AA2 7 LYS A 180 VAL A 190 -1 O LEU A 183 N VAL A 60 SHEET 4 AA2 7 SER A 159 GLY A 168 -1 N ARG A 163 O LEU A 186 SHEET 5 AA2 7 LEU A 98 ARG A 102 -1 N LEU A 98 O ILE A 162 SHEET 6 AA2 7 ILE A 108 PHE A 111 -1 O ARG A 109 N PHE A 101 SHEET 7 AA2 7 THR A 382 VAL A 384 -1 O ILE A 383 N LEU A 110 SHEET 1 AA3 2 LEU A 79 LEU A 81 0 SHEET 2 AA3 2 LEU B 79 LEU B 81 -1 O LEU B 79 N LEU A 81 SHEET 1 AA4 8 LYS A 305 GLU A 308 0 SHEET 2 AA4 8 GLU A 274 THR A 278 1 N LEU A 276 O LYS A 305 SHEET 3 AA4 8 MET A 261 ILE A 268 -1 N LEU A 265 O ALA A 277 SHEET 4 AA4 8 GLN A 254 VAL A 258 -1 N VAL A 258 O MET A 261 SHEET 5 AA4 8 GLN A 244 TYR A 249 -1 N TYR A 249 O GLN A 254 SHEET 6 AA4 8 VAL A 202 TRP A 205 1 N TRP A 205 O LEU A 246 SHEET 7 AA4 8 VAL A 336 TYR A 345 1 O LEU A 344 N LEU A 204 SHEET 8 AA4 8 GLU A 348 HIS A 351 -1 O ILE A 350 N ILE A 343 SHEET 1 AA5 6 LYS A 305 GLU A 308 0 SHEET 2 AA5 6 GLU A 274 THR A 278 1 N LEU A 276 O LYS A 305 SHEET 3 AA5 6 MET A 261 ILE A 268 -1 N LEU A 265 O ALA A 277 SHEET 4 AA5 6 VAL A 325 GLY A 332 -1 O GLU A 327 N TYR A 266 SHEET 5 AA5 6 VAL A 336 TYR A 345 -1 O VAL A 336 N GLY A 332 SHEET 6 AA5 6 GLU A 348 HIS A 351 -1 O ILE A 350 N ILE A 343 SHEET 1 AA6 6 ILE B 31 VAL B 32 0 SHEET 2 AA6 6 HIS B 72 PRO B 75 1 O ILE B 73 N ILE B 31 SHEET 3 AA6 6 HIS B 56 SER B 63 -1 N THR B 59 O HIS B 72 SHEET 4 AA6 6 LYS B 180 VAL B 190 -1 O LEU B 183 N VAL B 60 SHEET 5 AA6 6 SER B 159 GLY B 168 -1 N ARG B 163 O LEU B 186 SHEET 6 AA6 6 GLU B 93 PHE B 95 -1 N LEU B 94 O PHE B 166 SHEET 1 AA7 7 GLY B 67 TRP B 68 0 SHEET 2 AA7 7 HIS B 56 SER B 63 -1 N SER B 63 O GLY B 67 SHEET 3 AA7 7 LYS B 180 VAL B 190 -1 O LEU B 183 N VAL B 60 SHEET 4 AA7 7 SER B 159 GLY B 168 -1 N ARG B 163 O LEU B 186 SHEET 5 AA7 7 LEU B 98 ARG B 102 -1 N LEU B 98 O ILE B 162 SHEET 6 AA7 7 ILE B 108 PHE B 111 -1 O ARG B 109 N PHE B 101 SHEET 7 AA7 7 THR B 382 VAL B 384 -1 O ILE B 383 N LEU B 110 SHEET 1 AA8 8 LYS B 305 GLU B 308 0 SHEET 2 AA8 8 GLU B 274 THR B 278 1 N LEU B 276 O LYS B 305 SHEET 3 AA8 8 MET B 261 ILE B 268 -1 N LEU B 265 O ALA B 277 SHEET 4 AA8 8 GLN B 254 VAL B 258 -1 N VAL B 258 O MET B 261 SHEET 5 AA8 8 GLN B 244 TYR B 249 -1 N TYR B 249 O GLN B 254 SHEET 6 AA8 8 VAL B 202 TRP B 205 1 N TRP B 205 O LEU B 246 SHEET 7 AA8 8 VAL B 336 TYR B 345 1 O LEU B 344 N LEU B 204 SHEET 8 AA8 8 GLU B 348 HIS B 351 -1 O ILE B 350 N ILE B 343 SHEET 1 AA9 6 LYS B 305 GLU B 308 0 SHEET 2 AA9 6 GLU B 274 THR B 278 1 N LEU B 276 O LYS B 305 SHEET 3 AA9 6 MET B 261 ILE B 268 -1 N LEU B 265 O ALA B 277 SHEET 4 AA9 6 VAL B 325 GLY B 332 -1 O GLU B 327 N TYR B 266 SHEET 5 AA9 6 VAL B 336 TYR B 345 -1 O CYS B 338 N GLY B 330 SHEET 6 AA9 6 GLU B 348 HIS B 351 -1 O ILE B 350 N ILE B 343 SSBOND 1 CYS A 335 CYS A 338 1555 1555 2.04 SSBOND 2 CYS B 335 CYS B 338 1555 1555 1.97 LINK NZ LYS A 222 C4A PLP A 402 1555 1555 1.30 LINK NZ LYS B 222 C4A PLP B 402 1555 1555 1.31 LINK OD2 ASP B 133 MG MG B 403 1555 1555 2.05 LINK MG MG B 403 O HOH B 517 1555 1555 2.08 LINK MG MG B 403 O HOH B 556 1555 4445 2.14 LINK MG MG B 403 O HOH B 584 1555 4445 2.03 LINK MG MG B 403 O HOH B 615 1555 4445 2.12 LINK MG MG B 403 O HOH B 645 1555 1555 2.16 CISPEP 1 GLY A 358 PRO A 359 0 -1.40 CISPEP 2 GLY B 358 PRO B 359 0 0.85 CRYST1 66.986 106.316 108.982 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014928 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009406 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009176 0.00000